Clinical Trial Update: Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the impact of dexmedetomidine on postoperative delirium in patients following intracranial surgery for brain tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Diseases

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Capital Medical University | Conditions: Central Nervous System Diseases | Phase 4 | Status: COMPLETED